Team:Paris/July 31
From 2008.igem.org
(Difference between revisions)
(→Oligonucleotides design) |
AnaJimenez (Talk | contribs) (→Transformation results) |
||
Line 11: | Line 11: | ||
This plasmid can be used to amplify a promoter because only the promoter is in the biobrick. | This plasmid can be used to amplify a promoter because only the promoter is in the biobrick. | ||
<br><br><br><br><br><br><br><br><br><br> | <br><br><br><br><br><br><br><br><br><br> | ||
+ | |||
+ | ==Transformation results== | ||
==Transformation results== | ==Transformation results== | ||
Line 18: | Line 20: | ||
|align="center"|'''Nb of colonies''' | |align="center"|'''Nb of colonies''' | ||
|align="center"|'''Description''' | |align="center"|'''Description''' | ||
- | |align="center"|'''Volume''' | + | |align="center"|'''Volume gel extraction''' |
|- | |- | ||
|align="center"|L100 | |align="center"|L100 | ||
Line 142: | Line 144: | ||
|align="center"|L124 | |align="center"|L124 | ||
|align="center"|a lot ++ | |align="center"|a lot ++ | ||
- | |align="center"| | + | |align="center"|strongest RBS (1) <-> RFP |
- | |align="center"|6+ | + | |align="center"|6+5 |
|- | |- | ||
|align="center"|L125 | |align="center"|L125 | ||
|align="center"|a lot ++ | |align="center"|a lot ++ | ||
- | |align="center"| | + | |align="center"|strongest RBS (1) <-> YFP |
- | |align="center"|6+ | + | |align="center"|6+10 |
|- | |- | ||
|align="center"|L126 | |align="center"|L126 | ||
- | |align="center"| | + | |align="center"|no dish found!!! |
- | |align="center"| | + | |align="center"|strongest RBS (1) <-> activator (+LVA) |
- | |align="center"|6+ | + | |align="center"|6+4 |
|- | |- | ||
|align="center"|L127 | |align="center"|L127 | ||
- | |align="center"| | + | |align="center"|no dish found!!! |
- | |align="center"| | + | |align="center"|Double terminator <-> GFP |
- | |align="center"| | + | |align="center"|6+3 |
- | | | + | |- |
+ | |align="center"|'''Control''' | ||
+ | |align="center"| | ||
+ | |align="center"| | ||
+ | |align="center"| | ||
+ | |- | ||
+ | |align="center"|C1 | ||
+ | |align="center"|0 | ||
+ | |align="center"|D110 | ||
+ | |align="center"|3 | ||
+ | |- | ||
+ | |align="center"|C2 | ||
+ | |align="center"|5 | ||
+ | |align="center"|D129 | ||
+ | |align="center"|5 | ||
+ | |- | ||
+ | |align="center"|C3 | ||
+ | |align="center"|+/- 100 | ||
+ | |align="center"|D123 | ||
+ | |align="center"|5 | ||
+ | |- | ||
+ | |align="center"|C4 | ||
+ | |align="center"|+/- 20 | ||
+ | |align="center"|D103 | ||
+ | |align="center"|5 | ||
+ | |- | ||
+ | |align="center"|C5 | ||
+ | |align="center"|+/- 100 | ||
+ | |align="center"|Double terminator <-> GFP | ||
+ | |align="center"|4 | ||
+ | |- | ||
+ | |align="center"|C6 | ||
+ | |align="center"|+/- 100 | ||
+ | |align="center"|Double terminator <-> GFP | ||
+ | |align="center"|3 | ||
+ | |- | ||
+ | |align="center"|C7 | ||
+ | |align="center"|0 | ||
+ | |align="center"|Double terminator <-> GFP | ||
+ | |align="center"|5 | ||
+ | |- | ||
+ | |align="center"|C8 | ||
+ | |align="center"|+/- 20 | ||
+ | |align="center"|Double terminator <-> GFP | ||
+ | |align="center"|7 | ||
+ | |- | ||
+ | |align="center"|C9 | ||
+ | |align="center"|0 | ||
+ | |align="center"|Double terminator <-> GFP | ||
+ | |align="center"|4 | ||
+ | |- | ||
+ | |align="center"|C10 | ||
+ | |align="center"|0 | ||
+ | |align="center"|Double terminator <-> GFP | ||
+ | |align="center"|6 | ||
+ | |- | ||
+ | |align="center"|C11 | ||
+ | |align="center"|0 | ||
+ | |align="center"|Double terminator <-> GFP | ||
+ | |align="center"|7 | ||
+ | |- | ||
+ | |align="center"|C12 | ||
+ | |align="center"|+/- 10 | ||
+ | |align="center"|Double terminator <-> GFP | ||
+ | |align="center"|6 | ||
+ | |- | ||
+ | |align="center"|Positive control | ||
+ | |align="center"|155 (transformation efficiency:1.5*10^7/ug) | ||
+ | |align="center"|??? | ||
+ | |align="center"| | ||
|} | |} |
Revision as of 15:44, 4 August 2008
Oligonucleotides designCreation of 3 oligonucleotides (O140, O141, O142) in order to create two particular plasmids. Those plasmids are very useful vectors to amplify promoters and to measure their forces using Standard Promoter Units.
The principle is easy to understand.
Instead of using a big biobrick containing Promoter, RBS, GFP and Terminators, the Biobrick used for the test is only the Promoter. The standard GFP tripart (E0240) is between the biobrick site, it is just between two PstI restriction sites.
This plasmid can be used to amplify a promoter because only the promoter is in the biobrick.
Transformation resultsTransformation results
|